The Prognostic Significance of <i>FGFR4</i> Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy

Published:2016-01-15 Issue:1 Volume:48 Page:71-79
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Shim Hyun-Jeong,Shin Min-Ho,Kim Hee-Nam,Kim Jo-Heon,Hwang Jun-Eul,Bae Woo-Kyun,Chung Ik-Joo,Cho Sang-Hee

Funder

Chonnam National University Hwasun Hospital Institute for Biomedical Science

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2015-018.pdf

Reference24 articles.

1. Cancer statistics, 2012

2. Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy

3. A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer

4. Paclitaxel-Based Chemoradiotherapy in the Treatment of Patients With Operable Esophageal Cancer

5. Targeted Therapies with Chemoradiation in Esophageal Cancer: Development and Future Directions

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and prognostic value of circulating tumor cells in esophageal carcinoma: a meta-analysis;Annals of Palliative Medicine;2020-11

2. Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer;Translational Cancer Research;2020-11

3. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition;Cancer Research and Treatment;2020-05-25

4. Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas;Cells;2019-09-16

5. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer;Molecular Carcinogenesis;2018-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3